Drug intelligence / Profile preview

Tegretol + Auration

Development stage
Unknown
Lead developer
Novartis
Modality
Small Molecules
Administration
Oral
01

Overview

Tegretol + Auration appears to refer to a combination of two drugs, with "Tegretol" being the well-known brand name for carbamazepine, an anticonvulsant and analgesic used primarily for epilepsy (seizure disorders), trigeminal neuralgia, and bipolar disorder. Carbamazepine works by reducing abnormal electrical activity in the brain, likely through inhibition of voltage-gated sodium channels. The mechanism is not fully understood but involves blocking polysynaptic responses and post-tetanic potentiation[3][5][6][7]. However, there is no evidence from available sources that "Auration" is a recognized pharmaceutical agent or ingredient. It does not appear in drug databases or medical literature as a standalone medication or as part of any approved combination with Tegretol/carbamazepine. Therefore, this entry may be based on an incorrect or misspelled drug name.

02

Targets

SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)

Beyond the preview

Go deeper on Tegretol + Auration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tegretol + Auration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call